Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy

Cheng‐Ying Chu, Yi‐Ching Lee, Cheng-Han Hsieh, Chi‐Tai Yeh, Tsu‐Yi Chao, Po‐Hung Chen, I‐Hsuan Lin, Tsung‐Han Hsieh, Jing-Wen Shih, Chia‐Hsiung Cheng,

Theranostics · 2021 · 22 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

We uncovered TREM1/CCL2 activation, in addition to restored ASS1 expression, as a key pathway involved in full ADI-resistance in breast and prostate cancer models.